All Pharma articles – Page 21
-
NewsExclusive: NHS England delays treatment choices after legal threat
NHS England has cancelled key meetings at which it was due to decide whether to fund a series of treatments for serious conditions following a threat of judicial review, HSJ has learned.
-
NewsCCGs poised to defy pharma by switching to cheaper, unlicensed drug
Clinical commissioning groups across England are mulling the use of an unlicensed drug which could save the NHS millions of pounds, HSJ has learned
-
NewsNew NHS England partnership with pharma to speed up drug access
Government plans for closer working between the NHS and the pharmaceutical industry will make the new generation of precision medicines more affordable for the NHS, the minister for life sciences has said.
-
SupplementsSurvey results: putting pathology services to the test
How can healthcare organisations get the greatest benefit from pathology?
-
-
NewsPatients 'denied treatments' because of 'Kafkaesque' commissioning regime
Patients are being denied access to life changing treatments because parts of NHS England’s “Kafkaesque” commissioning regime appear to have ground to a halt, clinicians and charities have warned
-
NewsExpensive drugs to be cut from cancer drugs fund
NHS England is to start evaluating the cost effectiveness of medicines available through the cancer drugs fund in a bid to bring the budget under control
-
NewsExclusive: Labour could make NICE guidance mandatory
A Labour government could reduce variation in access to drugs and procedures by making it mandatory for commissioners to follow NICE guidelines, Andy Burnham has revealed
-
HSJ Local
Bath GPs to launch diabetes drug trial
CLINICAL RESEARCH: A network of GP surgeries around Bath has been selected as the site of a clinical trial for a diabetes drug from the pharmaceutical giant Pfizer.
-
NewsReturned drug money should not fund waiting list drive
The billions of pounds due to be clawed back from pharma firms under a new NHS pricing deal should not be diverted to help hospitals cut waiting lists, the head of the Association of British Pharmaceutical Industry has urged.
-
CommentIs big retail the therapy for NHS care?
Retailers expanding into primary care could work in the NHS
-
LeaderWeak spending pledges mean more rationing and tighter control
The debate about NHS finances is changing
-
NewsExclusive: NHS England could curb access to NICE approved drug
Patients could be denied access to a groundbreaking drug that cures Hepatitis C because the NHS cannot afford it, HSJ has learned.
-
SupplementsPatient experience special report: Quality care begins at home
Home monitoring can improve life for patients
-
HSJ KnowledgeReduce antipsychotic prescriptions to save dementia patients
GPs and pharmacists work together
-
SupplementsUnblock the system: how to treat DVT in the community
Innovative new treatments are saving NHS money
-
SupplementsSpecial report: The sticking point for medication adherence
Understanding patients’ reasons why
-
CommentCancer drug announcements must be backed up with action
There’s an element of pre-election tidying
-
News£160m boost for cancer drugs fund
Thousands more cancer patients in England will be offered vital treatments in a £160m boost to the cancer drugs fund, the Department of Health has said.
-
CommentMedicalising common ailments is one of healthcare's greatest threats
It stops long term changes